Chi Special Acquisition Corp. (GDST) appoints Chung Fu Wing and Shangwei Chen to board
Filing Impact
Filing Sentiment
Form Type
8-K
Rhea-AI Filing Summary
Chi Special Acquisition Corp. reported changes to its board of directors. Effective June 2, 2026, directors Pin Tai and Nan Sun resigned for personal reasons. On the same date, the company appointed Chung Fu Wing and Shangwei Chen to fill the resulting vacancies.
Chung Fu Wing, age 54, brings 30 years of multi-asset investment and management consulting experience in Asia, including prior roles in strategy and financial advisory. Shangwei Chen, age 41, adds more than 13 years of experience in investment advisory, corporate restructuring, and healthcare management, including founding SJ Investment and serving as Director and Executive Partner at NIEN TAI MEDICAL INSTRUMENTS.
Positive
- None.
Negative
- None.
8-K Event Classification
3 items: 5.02, 5.03, 9.01
3 items
Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers
Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
Item 5.03
Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Governance
The company amended its charter documents, bylaws, or changed its fiscal year.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Key Figures
Effective date of board changes: June 2, 2026
Age of director Chung Fu Wing: 54 years
Experience of Chung Fu Wing: 30 years
+3 more
6 metrics
Effective date of board changes
June 2, 2026
Date when resignations and new appointments became effective
Age of director Chung Fu Wing
54 years
Newly appointed director’s age and background
Experience of Chung Fu Wing
30 years
Multi-asset investment and management consulting experience in Asia
Age of director Shangwei Chen
41 years
Newly appointed director’s age and background
Experience of Shangwei Chen
over 13 years
Investment advisory, corporate restructuring, healthcare management
Warrant exercise price
$11.50 per whole share
Each redeemable warrant exercisable for one-half of one share of common stock
Key Terms
Emerging growth company, Redeemable Warrants, Inline XBRL, corporate restructuring, +1 more
5 terms
Emerging growth company regulatory
"Emerging growth company"
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
Redeemable Warrants financial
"Redeemable Warrants, each warrant exercisable for one-half of one share"
A redeemable warrant is a tradable right that lets its holder buy a company’s shares at a fixed price before a set date, but the issuer has the contract power to cancel (redeem) the warrant early under agreed terms. For investors this matters because early redemption can force decision-making, change the timing of when new shares might be created, and affect potential gains or dilution—much like a store coupon that the issuer can cancel by paying you off instead of letting you use it.
Inline XBRL technical
"Cover Page Interactive Data File (embedded within the Inline XBRL document)"
Inline XBRL is a file format for financial filings that embeds machine-readable data tags directly inside the human-readable report, so the same document can be read by people and parsed by software. For investors it makes extracting, comparing and verifying financial numbers faster and more reliable—like a grocery list where each item also has a barcode—reducing manual errors and speeding up analysis.
corporate restructuring financial
"experience in investment advisory, corporate restructuring, and healthcare management"
M&A due diligence financial
"with focus on corporate strategy, M&A due diligence, and post-merger integration"
FAQ
What board changes did Chi Special Acquisition Corp. (GDST) disclose?
Chi Special Acquisition Corp. disclosed that directors Pin Tai and Nan Sun resigned for personal reasons, effective June 2, 2026. On the same date, the board appointed Chung Fu Wing and Shangwei Chen to fill the resulting vacancies, maintaining the board’s composition and continuity.
Why did directors Pin Tai and Nan Sun leave Chi Special Acquisition Corp. (GDST)?
The filing states that directors Pin Tai and Nan Sun resigned for personal reasons effective June 2, 2026. It does not mention any dispute or disagreement with the company, indicating a personal, rather than conflict-driven, reason for their departures from the board.
Who is new director Chung Fu Wing at Chi Special Acquisition Corp. (GDST)?
Chung Fu Wing, age 54, is a new director with 30 years of experience in multi-asset investment and management consulting in Asia. He is described as an award-winning fund manager with deep insight into Asian and global capital markets and prior experience at major consulting firms.
What experience does new director Shangwei Chen bring to Chi Special Acquisition Corp. (GDST)?
Shangwei Chen, age 41, brings over 13 years of experience in investment advisory, corporate restructuring, and healthcare management. He is Founder and Managing Partner of SJ Investment and serves as Director and Executive Partner at NIEN TAI MEDICAL INSTRUMENTS, focusing on strategic modernization and portfolio expansion.
Does the Chi Special Acquisition Corp. (GDST) 8-K mention any financial results?
This 8-K centers on board changes and does not provide financial results or earnings data. It primarily describes director resignations, new appointments, and background information on the incoming directors, without discussing revenue, profits, or other financial performance metrics.
What securities are referenced for Chi Special Acquisition Corp. (GDST) in this filing?
The filing references units consisting of one share of common stock, one redeemable warrant, and one right, as well as separate common stock and redeemable warrants. Each redeemable warrant is exercisable for one-half of one share of common stock at an exercise price of $11.50 per whole share.